May 21, 2026 Medical & Allied Health

What Goes Into a Pathology Lab Commercial Mortgage

Buying the premises your pathology lab operates from is a considered step for any operator, and it puts the controlled environment your work depends on under your own control. At Ardent Capital Group we speak with lab owners about this kind of commercial property purchase, and this guide walks through how a lender reads a specialised laboratory building.

Ardent Capital Group is a specialist in commercial mortgages for pathology lab operators across Australia. Our team can help you move from tenant to owner, and give you clear lending advice on structure and strategy.

Funding scope: Access finance from $100,000 to $10,000,000+ for premises purchase, fit-out and related needs.
Track record: Over $500,000,000 facilitated across a decade for business borrowers.
National coverage: Sydney, Melbourne, Brisbane, Perth, Adelaide, Canberra, Hobart and surrounding regional towns.
Sector focus: Medical, dental, allied health and laboratory properties, with lender panels that understand healthcare cash flows.

Reasons to own your premises

Ownership lets you control the high-spec environment your lab depends on. Pathology operations need HVAC with filtration, stable power for analysers and cold chain equipment, compliant biohazard zones, secure sample handling and room for courier access. Each relocation risks downtime, re-certification and cost. In many suburbs, your referrers and collection volumes are anchored to the address, especially near hospitals, GP super clinics and medical precincts. The sector has resilient demand supported by Medicare rebates and hospital contracts, and repayments convert occupancy cost into equity in an owned asset.

Main drivers:

Protect the fit-out investment: High-cost items like immunoassay and chemistry analysers, PCR platforms, biosafety cabinets, cryogenic and vaccine-grade freezers, UPS and generator backup, water purification and specialised plumbing are best amortised in one location over time.
Operational continuity: Control over lease terms, layout and compliance helps maintain NATA accreditation and turnaround times.
Location equity: Proximity to referrers and reliable courier routes supports specimen flow and revenue consistency.
Build a balance sheet asset: Principal repayments grow equity and can reduce long-run occupancy cost versus escalating rent.

Buying may not suit if your lease tail is short with a likely relocation, if you are planning to consolidate sites after contract changes, or if capital is better deployed into new analysers, LIS upgrades or reagent agreements to lift throughput. The decision sits with you and your growth plan.

How the finance works for a pathology lab

Deposit and LVR. A pathology laboratory is a specialised licensed asset, so a valuer assesses it on a specialised-use basis and treats the single-use fit-out conservatively. Owner-occupier lending on the building commonly sits around 60 to 70 per cent of value, which means a deposit in the order of 30 to 40 per cent. The land and base building carry the value a lender relies on, and the analysers and lab equipment are usually financed separately.

Loan term and structure. Terms commonly run from around 10 to 15 years with the banks and out to 25 to 30 years with non-bank lenders. Facilities can be principal and interest for steady amortisation, or interest only for a period to prioritise cash flow during fit-out, equipment commissioning or onboarding new referrers.

Security and serviceability. The property is the primary security. Lenders assess business financials, serviceability from lab earnings, the stability of referrer and contract income, and the valuation of the building including the specialised services that add value.

Owner-occupier treatment. Lenders typically view owner-occupied medical and laboratory premises favourably, given resilient demand, lower vacancy risk and the alignment between the operator and the property.

How the purchase is usually structured

Many operators hold the property in a separate entity, such as a company or trust, which leases the premises to the trading lab at a commercial rent. This sets a clear line between the operating risks of the pathology business and the property asset, and a lender then reads the inter-entity rent as the serviceability line.

SMSF option. Commercial premises generally qualify as business real property, so an SMSF can hold the building and lease it back to the trading lab at a market rate. The appeal includes asset protection and a concessional tax environment; the trade-offs include contribution caps, liquidity requirements, higher set-up costs and limited recourse lending. Ardent structures the finance around the arrangement you and your accountant have chosen, and your accountant confirms the super, tax and ownership detail before anything is locked in.

What underwriters focus on

Business financials and serviceability: Multi-site revenue, gross margins after reagents and consumables, EBITDA, stability of referrer base and contract mix including Medicare, private billing and hospital work.
Track record and compliance: Years trading, NATA accreditation status, quality systems, LIS integration and evidence of uninterrupted operations.
Property and valuation: Zoning for medical or laboratory use, services capacity such as three-phase power, HVAC and extraction, cold storage space, biohazard waste handling and courier access.
Deposit and equity position: Cash, retained earnings, or the ability to leverage your equity in other property.
Lease and occupancy: If buying with a short lease tail before moving, lenders want the relocation plan. For sale-and-leaseback or multi-tenant sites, they assess lease strength and WALE.
Directors and guarantors: Credit history, ATO position and asset backing where required.

A specialist broker who works daily with medical and laboratory lenders helps present the credit story in the way underwriters expect, which matters in the pathology sector.

A worked example

This is an illustrative scenario that shows the kind of situation we can assist with, and how the thinking might run.

Situation: An independent pathology operator in Melbourne wants to buy the 650 sqm central lab it has leased for three years. The site has upgraded HVAC, a 200 kVA backup generator and validated cold rooms, and rent escalations are squeezing margin.
Objectives: Fix occupancy cost, expand the microbiology footprint, retain courier access and maintain NATA continuity through the transition.
Options we would map:
- A company trustee for a family trust to own the property and lease it back to the trading entity at market rent aligned to valuation.
- An SMSF purchase with limited recourse borrowing, weighing the liquidity and contribution constraints.
- Financing the building on its specialised-use valuation while the analysers and fit-out fine-tuning are funded separately under equipment finance, keeping cash in the business.
Likely lending guide (subject to valuation and serviceability): Around 60 to 70 per cent LVR on the specialised laboratory building, with the analysers and moveable equipment assessed separately.
Decision lens: Cash flow under principal and interest versus interest only while new equipment ramps, rent setting for the related-party lease, and accreditation continuity.
How we would approach it: We would map the ranges, structures and repayments, then work alongside the operator's accountant on the final confirmation. The figures above are illustrative, not confirmed outcomes.

Beyond the mortgage: pathology lab finance

Asset finance for pathology equipment: Fund chemistry and immunoassay analysers, PCR platforms, centrifuges, cryogenic storage, biosafety cabinets and UPS, arranged as pathology lab equipment finance to match each item to its asset life.
Fit-out and refurbishment finance: Support HVAC upgrades, negative-pressure rooms, validated cold chain, plumbing and clean-room finishes without straining working capital.
Working capital loans: Smooth reagent and consumable costs, buffer against payment cycles and manage seasonal test volumes with working capital for a pathology lab.
Business overdraft: Flexible line for short-dated needs like courier surges, minor repairs and urgent replacement of critical components.
Refinancing and debt consolidation: Reprice legacy facilities, simplify multiple equipment schedules and align repayments with cash generation.
Construction and renovation: Build or expand a central lab, add collection rooms and design flows for accessioning, processing and dispatch.
Business or premises acquisition finance: Buy a strata suite for a collection centre, acquire a competitor book or buy out partners.

These facilities can work together. Owning the premises can free equity for future equipment upgrades, and a refinance can consolidate older schedules into a cleaner structure.

Working with a pathology lab finance specialist

Ardent Capital Group arranges and structures commercial mortgages for pathology lab owners, aligning the facility with how you plan to hold and occupy the building. We shape the lending to fit your entity structure, lease arrangements and operational timeline.

We service Sydney, Melbourne, Brisbane, Gold Coast, Perth, Adelaide, Canberra and surrounding metro and regional areas. We have helped facilitate over $500,000,000 in funding across a decade for over 1,000 borrowers. If you are weighing a pathology lab property loan, talk to us about a clear plan for optimal financial outcomes.

Common questions

How much deposit do I need to buy a pathology lab premises? A pathology laboratory is valued on a specialised-use basis, so owner-occupier lending commonly sits around 60 to 70 per cent of value, which means a deposit in the order of 30 to 40 per cent. The analysers and lab equipment are usually financed separately.

Can I buy the lab building in my SMSF and lease it back to my practice? Yes, commercial property generally qualifies as business real property. An SMSF can hold it and lease back to your lab at a market rate, subject to limited recourse lending rules and liquidity requirements.

Do lenders treat owner-occupied lab properties more favourably than investments? Typically yes. Owner-occupier pathology and medical assets are viewed as lower vacancy risk, which lenders take into account when they assess the file.

Will the valuation recognise my lab-specific fit-out and services? Valuers consider permanent improvements and services that add enduring value, such as power upgrades, HVAC, waste handling and compliant rooms. Single-use fit-out is treated conservatively, and moveable equipment is usually assessed separately under asset finance.

What documents will lenders want from a pathology operator? Financial statements and BAS, aged payables and receivables, details of referrer and contract mix, evidence of NATA accreditation, property information and a rent plan for any related-party lease.

How fast can a commercial mortgage settle for a lab purchase? With clean financials, valuation access and a clear structure, four to eight weeks is common. Complex builds, SMSF borrowing or strata body issues can extend timeframes.

Written by

Nick Chong

Managing Director, M.AppFin, Dip. Mortgage Mgmt

Nick holds a Bachelor of Agricultural Economics, a Master of Applied Finance and an Advanced Diploma in Financial Planning. He founded Ardent Capital in 2016 after more than a decade in financial planning and mortgage broking. For the past ten years he has led a team of finance specialists, mortgage advisers, brokers and credit analysts, all working to secure optimal outcomes for clients and always acting in their best interests. The team brings both a qualitative and a quantitative approach to every deal.